SELLAS Life Sciences Announces Positive Final Data in Triple Negative Breast Cancer Patients from Phase 2b Clinical Trial of Nelipepimut-S Pharmaceutical Investing
CytomX Therapeutics Presents Clinical Data from Probody Platform and CX-072 at 2018 ESMO Annual Meeting Pharmaceutical Investing
DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration Biotech Investing
Isodiol International Inc. Announces CBD Beverage Expansion Plans Through Florida Based Subsidiary, IsoBev Cannabis Investing News
MediPharm Labs Corp. Bolsters Leadership & Operational Expertise to Further Accelerate Growth Cannabis Investing News
Life Science Big News Roundup: Biocure: Breakthrough Pre-Clinical Trial Results for CAR-T Cells Treatment; Isodiol Announces ISO-SPORT™ Products Now Available Life Science Investing
Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA Pharmaceutical Investing
Shire: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks Company News
Anavex Life Sciences Announces FDA Approval of IND for Phase 2 Trial of ANAVEX2-73 Pharmaceutical Investing
Naturally Splendid Appoints Dr. Lorne Swetlikoff to Advisory Board as Medical Advisor Cannabis Investing News
